1191127-63-5 Usage
General Description
1,3,4,6-Tetra-o-acetyl-2-amino-2-desoxy-D-glucopyranose hydrochloride is a chemical compound that is used in medical research and drug development. 1,3,4,6-Tetra-o-acetyl-2-amino-2-desoxy-D-glucopyranose hydrochloride is a derivative of D-glucopyranose, a type of sugar, and is acetylated at four positions. It contains an amino group and a desoxy (lacking oxygen) configuration. The hydrochloride salt form of this compound is commonly used in laboratory settings due to its stability and solubility. 1,3,4,6-Tetra-o-acetyl-2-amino-2-desoxy-D-glucopyranose hydrochloride is of interest for its potential biological and pharmaceutical properties, and may be used in the synthesis of carbohydrate-based drugs or as a building block for complex organic molecules. Its precise applications and properties are the subject of ongoing research in the field of organic chemistry and pharmaceutical science.
Check Digit Verification of cas no
The CAS Registry Mumber 1191127-63-5 includes 10 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 7 digits, 1,1,9,1,1,2 and 7 respectively; the second part has 2 digits, 6 and 3 respectively.
Calculate Digit Verification of CAS Registry Number 1191127-63:
(9*1)+(8*1)+(7*9)+(6*1)+(5*1)+(4*2)+(3*7)+(2*6)+(1*3)=135
135 % 10 = 5
So 1191127-63-5 is a valid CAS Registry Number.
1191127-63-5Relevant articles and documents
Profiling of: Haemophilus influenzae strain R2866 with carbohydrate-based covalent probes
Metier, Camille,Dow, Jennifer,Wootton, Hayley,Lynham, Steven,Wren, Brendan,Wagner, Gerd K.
, p. 476 - 485 (2021/01/29)
We demonstrate the application of four covalent probes based on anomerically pure d-galactosamine and d-glucosamine scaffolds for the profiling of Haemophilus influenzae strain R2866. The probes have been used successfully for the labelling of target prot
GOLD COMPOSITIONS AND METHODS OF USE THEREOF
-
Paragraph 0089; 0090, (2020/03/05)
Gold compounds and pharmaceutically acceptable salts thereof are disclosed. Certain compounds and salts are active as antibacterial, antifungal, and/or anti-parasitic agents. The disclosure provides pharmaceutical compositions containing the gold compounds. Methods of using the gold compounds to treat bacterial infections are disclosed.
GLYCOSYLATED 3-SUBSTITUTED FLUOROQUINOLONE DERIVATIVES, PREPARATION METHODS THEREOF, AND THEIR USE IN THE TREATMENT OF ANTIMICROBIAL INFECTIONS
-
Paragraph 036; 037, (2020/10/20)
The present disclosure relates to 3-substituted fluoroquinolone derivatives, and more particularly to glycosylated 3-substitutred fluoroquinolone derivatives, methods of preparation thereof, and uses thereof for treating microbial infections.